Chemoinformaics analysis of Cyanidin 3-O-beta-D-sambubioside
| Molecular Weight | 581.503 | nRot | 6 |
| Heavy Atom Molecular Weight | 552.271 | nRig | 21 |
| Exact Molecular Weight | 581.15 | nRing | 5 |
| Solubility: LogS | -6.36 | nHRing | 3 |
| Solubility: LogP | 7.684 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 70 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 2 |
| nHetero | 15 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 29 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 17 |
| nHA | 14 | APOL | 74.787 |
| nHD | 10 | BPOL | 37.773 |
| QED | 0.47 |
| Synth | 4.437 |
| Natural Product Likeliness | 2.475 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.388 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.733 |
| MDCK | 0.00000886 |
| BBB | 0.606 |
| PPB | 0.955297 |
| VDSS | 6.603 |
| FU | 0.0141521 |
| CYP1A2-inh | 0.071 |
| CYP1A2-sub | 0.285 |
| CYP2c19-inh | 0.095 |
| CYP2c19-sub | 0.868 |
| CYP2c9-inh | 0.109 |
| CYP2c9-sub | 0.267 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.494 |
| CYP3a4-inh | 0.25 |
| CYP3a4-sub | 0.31 |
| CL | 16.147 |
| T12 | 0.02 |
| hERG | 0.041 |
| Ames | 0.021 |
| ROA | 0.024 |
| SkinSen | 0.253 |
| Carcinogencity | 0.043 |
| EI | 0.013 |
| Respiratory | 0.624 |
| NR-Aromatase | 0.138 |
| Antiviral | Yes |
| Prediction | 0.811625 |